411 related articles for article (PubMed ID: 28645584)
1. Effects of intranasal treatment with slow (GYY4137) and rapid (NaHS) donors of hydrogen sulfide in lipopolysaccharide-induced airway inflammation in mice.
Kaya-Yasar Y; Karaman Y; Bozkurt TE; Onder SC; Sahin-Erdemli I
Pulm Pharmacol Ther; 2017 Aug; 45():170-180. PubMed ID: 28645584
[TBL] [Abstract][Full Text] [Related]
2. Hydrogen sulfide donors prevent lipopolysaccharide-induced airway hyperreactivity in an in vitro model of chronic inflammation in mice.
Karaman Y; Kaya-Yasar Y; Bozkurt TE; Sahin-Erdemli I
Basic Clin Pharmacol Toxicol; 2021 May; 128(5):652-660. PubMed ID: 33369105
[TBL] [Abstract][Full Text] [Related]
3. The effect of mitochondria-targeted slow hydrogen sulfide releasing donor AP39-treatment on airway inflammation.
Karaman Y; Kaya-Yasar Y; Eylem CC; Onder SC; Nemutlu E; Bozkurt TE; Sahin-Erdemli I
Eur J Pharmacol; 2023 May; 946():175619. PubMed ID: 36828102
[TBL] [Abstract][Full Text] [Related]
4. GYY4137, a novel hydrogen sulfide-releasing molecule, protects against endotoxic shock in the rat.
Li L; Salto-Tellez M; Tan CH; Whiteman M; Moore PK
Free Radic Biol Med; 2009 Jul; 47(1):103-13. PubMed ID: 19375498
[TBL] [Abstract][Full Text] [Related]
5. The route and timing of hydrogen sulfide therapy critically impacts intestinal recovery following ischemia and reperfusion injury.
Jensen AR; Drucker NA; Te Winkel JP; Ferkowicz MJ; Markel TA
J Pediatr Surg; 2018 Jun; 53(6):1111-1117. PubMed ID: 29622397
[TBL] [Abstract][Full Text] [Related]
6. H2S Attenuates LPS-Induced Acute Lung Injury by Reducing Oxidative/Nitrative Stress and Inflammation.
Zhang HX; Liu SJ; Tang XL; Duan GL; Ni X; Zhu XY; Liu YJ; Wang CN
Cell Physiol Biochem; 2016; 40(6):1603-1612. PubMed ID: 28006762
[TBL] [Abstract][Full Text] [Related]
7. H
Yurinskaya MM; Krasnov GS; Kulikova DA; Zatsepina OG; Vinokurov MG; Chuvakova LN; Rezvykh AP; Funikov SY; Morozov AV; Evgen'ev MB
Inflamm Res; 2020 May; 69(5):481-495. PubMed ID: 32157318
[TBL] [Abstract][Full Text] [Related]
8. Effects of fast versus slow-releasing hydrogen sulfide donors in hypertension in pregnancy and fetoplacental growth restriction.
Zochio GP; Possomato-Vieira JS; Chimini JS; da Silva MLS; Dias-Junior CA
Naunyn Schmiedebergs Arch Pharmacol; 2019 Dec; 392(12):1561-1568. PubMed ID: 31363805
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen sulfide limits neutrophil transmigration, inflammation, and oxidative burst in lipopolysaccharide-induced acute lung injury.
Faller S; Hausler F; Goeft A; von Itter MA; Gyllenram V; Hoetzel A; Spassov SG
Sci Rep; 2018 Oct; 8(1):14676. PubMed ID: 30279441
[TBL] [Abstract][Full Text] [Related]
10. Parenteral Na
Drapala A; Koszelewski D; Tomasova L; Ostaszewski R; Grman M; Ondrias K; Ufnal M
Acta Biochim Pol; 2017; 64(3):561-566. PubMed ID: 28753683
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of hydrogen sulfide on ozone-induced airway inflammation, oxidative stress, and bronchial hyperresponsiveness.
Zhang P; Li F; Wiegman CH; Zhang M; Hong Y; Gong J; Chang Y; Zhang JJ; Adcock I; Chung KF; Zhou X
Am J Respir Cell Mol Biol; 2015 Jan; 52(1):129-37. PubMed ID: 25010831
[TBL] [Abstract][Full Text] [Related]
12. The effects of fatty acid amide hydrolase and monoacylglycerol lipase inhibitor treatments on lipopolysaccharide-induced airway inflammation in mice.
Abohalaka R; Bozkurt TE; Nemutlu E; Onder SC; Sahin-Erdemli I
Pulm Pharmacol Ther; 2020 Jun; 62():101920. PubMed ID: 32416152
[TBL] [Abstract][Full Text] [Related]
13. The complex effects of the slow-releasing hydrogen sulfide donor GYY4137 in a model of acute joint inflammation and in human cartilage cells.
Li L; Fox B; Keeble J; Salto-Tellez M; Winyard PG; Wood ME; Moore PK; Whiteman M
J Cell Mol Med; 2013 Mar; 17(3):365-76. PubMed ID: 23356870
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen sulfide ameliorates acute lung injury induced by infrarenal aortic cross-clamping by inhibiting inflammation and angiopoietin 2 release.
Tang B; Ma L; Yao X; Tan G; Han P; Yu T; Liu B; Sun X
J Vasc Surg; 2017 Feb; 65(2):501-508.e1. PubMed ID: 26781077
[TBL] [Abstract][Full Text] [Related]
15. GYY4137 attenuates LPS-induced acute lung injury via heme oxygenase-1 modulation.
Jiang L; Jiang Q; Yang S; Huang S; Han X; Duan J; Pan S; Zhao M; Guo S
Pulm Pharmacol Ther; 2019 Feb; 54():77-86. PubMed ID: 30605726
[TBL] [Abstract][Full Text] [Related]
16. [Influence of the Donor of Hydrogen Sulfide GYY4137 on the Activation of Human Neutrophils by E. coli Lipopolysaccharides].
Petrushanko IY; Melnikova EV; Yurinskaya MM; Vinokurov MG; Suslikov AV; Mitkevich VA; Makarov AA
Mol Biol (Mosk); 2019; 53(1):101-108. PubMed ID: 30895957
[TBL] [Abstract][Full Text] [Related]
17. Hydrogen sulfide donor GYY4137 attenuates vascular complications in mesenteric bed of streptozotocin-induced diabetic rats.
Alshahwan H; Qabazard B; Mousa A; Chandrasekhar B; Santhosh K; Yousif MHM
Eur J Pharmacol; 2022 Oct; 933():175265. PubMed ID: 36108734
[TBL] [Abstract][Full Text] [Related]
18. Hydrogen sulfide donor, NaHS, stimulates ANP secretion via the K
Yu L; Park BM; Ahn YJ; Lee GJ; Kim SH
Peptides; 2019 Jan; 111():89-97. PubMed ID: 29684589
[TBL] [Abstract][Full Text] [Related]
19. The inhibitory role of hydrogen sulfide in airway hyperresponsiveness and inflammation in a mouse model of asthma.
Zhang G; Wang P; Yang G; Cao Q; Wang R
Am J Pathol; 2013 Apr; 182(4):1188-95. PubMed ID: 23395089
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of synthetic somatostatin receptor subtype 4 agonists on acute and chronic airway inflammation and hyperreactivity in the mouse.
Elekes K; Helyes Z; Kereskai L; Sándor K; Pintér E; Pozsgai G; Tékus V; Bánvölgyi A; Németh J; Szuts T; Kéri G; Szolcsányi J
Eur J Pharmacol; 2008 Jan; 578(2-3):313-22. PubMed ID: 17961545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
